Becton, Dickinson and (NYSE:BDX) Price Target Raised to $295.00 at Morgan Stanley
Becton, Dickinson and (NYSE:BDX) Price Target Raised to $295.00 at Morgan Stanley
Becton, Dickinson and (NYSE:BDX – Get Rating) had its price objective increased by Morgan Stanley from $290.00 to $295.00 in a research note issued to investors on Friday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical instruments supplier's stock.
据Benzinga报道，在周五上午发布给投资者的一份研究报告中，贝顿、迪金森和(纽约证券交易所代码：BDX-GET评级)将摩根士丹利的目标价从290.00美元上调至295.00美元。该经纪公司目前对这家医疗器械供应商的股票评级为增持。
Several other equities analysts also recently weighed in on the stock. William Blair reissued an outperform rating on shares of Becton, Dickinson and in a research note on Friday, November 11th. Cowen reduced their price objective on Becton, Dickinson and to $255.00 in a research report on Wednesday, November 16th. Piper Sandler upped their target price on Becton, Dickinson and from $245.00 to $260.00 and gave the company a neutral rating in a report on Thursday. Evercore ISI reduced their price target on Becton, Dickinson and to $270.00 in a report on Wednesday, November 16th. Finally, Bank of America raised shares of Becton, Dickinson and from a neutral rating to a buy rating and upped their price objective for the company from $250.00 to $290.00 in a report on Tuesday, January 3rd. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of Moderate Buy and a consensus target price of $275.64.
其他几位股票分析师最近也加入了该股的行列。威廉·布莱尔在11月11日星期五的一份研究报告中重新发布了对Becton，Dickinson和的股票的表现优于大盘的评级。考恩在11月16日(星期三)的一份研究报告中将他们对Becton和Dickinson的目标价格下调至255.00美元。派珀·桑德勒在周四的一份报告中将贝顿、迪金森和迪金森的目标价从245.00美元上调至260.00美元，并给予该公司中性评级。在11月16日周三的一份报告中，Evercore ISI将他们对Becton和Dickinson的目标价下调至270.00美元。最后，在1月3日周二的一份报告中，美国银行将Becton和Dickinson的股票评级从中性上调至买入，并将该公司的目标价从250.00美元上调至290.00美元。三位分析师对该股的评级为持有，六位分析师对该公司股票的评级为买入。根据MarketBeat的数据，该公司目前的平均评级为中等买入，共识目标价为275.64美元。
Becton, Dickinson and Stock Down 1.1 %
Becton，Dickinson和股价下跌1.1%
BDX stock opened at $245.84 on Friday. The stock has a market capitalization of $69.88 billion, a P/E ratio of 46.38, a P/E/G ratio of 2.13 and a beta of 0.54. Becton, Dickinson and has a 52 week low of $215.90 and a 52 week high of $280.62. The firm has a 50-day simple moving average of $251.67 and a 200-day simple moving average of $244.48. The company has a quick ratio of 0.63, a current ratio of 1.07 and a debt-to-equity ratio of 0.56.
上周五，BDX股价开盘报245.84美元。该股市值为698.8亿美元，市盈率为46.38，市盈率为2.13，贝塔系数为0.54。贝顿，迪金森，并有52周低点215.90美元和52周高点280.62美元。该公司的50日简单移动均线切入位在251.67美元，200日简单移动均线切入位在244.48美元。该公司的速动比率为0.63，流动比率为1.07，债务权益比率为0.56。
Becton, Dickinson and Dividend Announcement
贝顿、狄金森和股息公告
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 31st. Shareholders of record on Friday, March 10th will be paid a $0.91 dividend. The ex-dividend date is Thursday, March 9th. This represents a $3.64 annualized dividend and a dividend yield of 1.48%. Becton, Dickinson and's dividend payout ratio (DPR) is 68.68%.
该公司最近还宣布了季度股息，将于3月31日(星期五)支付。3月10日(星期五)登记在册的股东将获得0.91美元的股息。除息日期为3月9日(星期四)。这意味着年化股息为3.64美元，股息收益率为1.48%。Becton，Dickinson and的股息支付率(DPR)为68.68%。
Institutional Inflows and Outflows
机构资金流入和流出
A number of hedge funds and other institutional investors have recently bought and sold shares of BDX. Red Tortoise LLC acquired a new position in Becton, Dickinson and during the 4th quarter worth approximately $25,000. Legend Financial Advisors Inc. lifted its holdings in Becton, Dickinson and by 105.6% during the 4th quarter. Legend Financial Advisors Inc. now owns 111 shares of the medical instruments supplier's stock worth $28,000 after buying an additional 57 shares during the last quarter. Trifecta Capital Advisors LLC acquired a new position in shares of Becton, Dickinson and during the 4th quarter worth about $31,000. Western Pacific Wealth Management LP purchased a new position in shares of Becton, Dickinson and in the 3rd quarter valued at about $30,000. Finally, Chilton Capital Management LLC purchased a new stake in Becton, Dickinson and during the second quarter worth approximately $39,000. 87.08% of the stock is currently owned by hedge funds and other institutional investors.
一些对冲基金和其他机构投资者最近买卖了BDX的股票。红乌龟有限责任公司在迪金森的贝顿获得了一个新的头寸，并在第四季度获得了大约2.5万美元的价值。联想金融顾问公司(Legend Financial Advisors Inc.)在第四季度增持了贝顿、迪金森的股份，增持幅度为105.6%。联想金融顾问公司现在拥有111股这家医疗器械供应商的股票，价值28,000美元，在上个季度又购买了57股。Trifeta Capital Advisors LLC在第四季度收购了Becton，Dickinson的新股票，价值约3.1万美元。西太平洋财富管理公司在第三季度购买了Becton，Dickinson的新股票头寸，价值约30,000美元。最后，Chilton Capital Management LLC在第二季度购买了Becton，Dickinson的新股份，价值约3.9万美元。87.08%的股票目前由对冲基金和其他机构投资者持有。
Becton, Dickinson and Company Profile
贝顿、狄金森和公司简介
(Get Rating)
(获取评级)
Becton, Dickinson & Co engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery.
Becton，Dickinson&Co从事医疗用品、设备、实验室设备和诊断产品的开发、制造和销售。它通过以下部门开展业务：BD医疗、BD生命科学和BD Intervative。BD医疗部门生产医疗技术和设备，用于帮助改善医疗保健服务。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Becton, Dickinson and (BDX)
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- 免费获取StockNews.com关于Becton、Dickinson和(BDX)的研究报告
- 市场回顾周-1/30-2/3
- 细价股值得吗？你应该投资细价股吗？
- Zimmer Biomet盈利节节攀升，增长可能被计入价格
- 人工智能软件制造商EPAM号称科技板块涨幅最大
- 福特股票在盈利大幅下滑后继续前进
Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.
接受Becton Dickinson和Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Becton Dickinson和相关公司的最新新闻和分析师评级的每日简要摘要。